Arexvy: Canada approves GSK’s RSV vaccine
GSK has received Canadian approval for Arexvy, its respiratory syncytial virus vaccine in adults between… Read More
9 months ago
RSV
Pfizer RSV vaccine 82% effective vs severe infection
Pfizer's experimental respiratory syncytial virus (RSV) vaccine was 82% effective in preventing severe infections in… Read More
2 years ago